Articles by Erin Hiatt

Erin Hiatt
Author
Erin Hiatt
Erin Hiatt is a New York City-based writer who has been covering the cannabis industry for more than six years. Her work - which has appeared in Hemp Connoisseur Magazine, PotGuide, Civilized, Vice, Freedom Leaf, MERRY JANE, Alternet, and CannaInvestor - covers a broad range of topics, including cannabis policy and law, CBD, hemp law and applications, science and technology, beauty, and psychedelics. Erin's work and industry insights have been featured on the podcasts The Let's Go Eat Show, In the Know 420, and she has appeared as a featured panelist on the topic of hemp media. Erin has interviewed top industry experts such as Dr. Carl Hart, Ethan Nadelmann, Amanda Feilding, Mark A.R. Kleiman, Dr. James Fadiman, and culture icons Governor Jesse Ventura, and author Tom Robbins. You can follow her work on LinkedIn, Wordpress, @erinhiatt on Twitter, and @erinisred on Instagram.

The Best Sugar-Free Edibles

Have you ever wanted edibles but could only find high sugar options? We feel your pain! Check out our top picks for sugar-free edibles, so you can stay medicated, minus the calories.
by - June 30, 2022

Private Cannabis Clubs & Personal Groups

Smoking cannabis, for most people, is enjoyed more with the company of others. If you’re looking to get out of house and start a new hobby or meet new weed lovin’ friends, check out these private clubs. You might be surprised that they were right under your nose this whole time.
by - June 22, 2022

How to Roll a Vortex Blunt

When it comes to blunts, there are lots of options between the wraps and the way people roll them. One popular rolling technique is creating a hollow, donut-shaped blizzy also known as the Vortex blunt. They provide a smoother draw and offer larger hits of smoke. 
by - June 10, 2022

Big Pharma And Synthetic Cannabis

With rumors of federal legalization lurking around the corner, Big Pharma may be gearing up to make cannabis available with purchase over the counter or via a prescription. Wikileaf takes a deep dive to see if this could happen within the foreseeable future and what it would take to pass with the FDA.
by - June 4, 2022
1 2